Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15-16
pubmed:dateCreated
1990-1-25
pubmed:abstractText
In treating candida vulvovaginitis attention has to be paid to the infection itself as well as to the importance of favouring conditions. With acute or non-recurring candida vulvovaginitis topical antimycotics have proved to be successful. In case of unsuccessful therapy or recurrence or chronicity the application of an intermitting topical or oral therapy is advised for an extended period of time, during or before the general symptoms, mainly premenstrually, occur. Today, an alternative to local therapy the short term application of modern oral azoles, Ketoconazole, Itraconazole, Fluconazole is suggested since no side effects are to be expected for short-time treatment. Thus adhesion-inhibitors might become a new possibility in therapy.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0043-5341
pubmed:author
pubmed:issnType
Print
pubmed:day
31
pubmed:volume
139
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
345-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
[General and advanced aspects of treatment of vulvovaginal mycosis].
pubmed:affiliation
Universitätsklinik für Dermatologie und Venerologie, Graz.
pubmed:publicationType
Journal Article, Comparative Study, English Abstract, Review